Key result
Combined assessment of serum endothelial, hepatic, and lipoprotein lipases provided better predictive power for coronary artery disease than HDL-c, and EL independently predicted in-stent restenosis.
Why the study?
Whether endothelial lipase, hepatic lipase, and lipoprotein lipase can be simultaneous independent risk factors for CAD and whether their combination provides greater predictive power than HDL-c was unknown.
Are serum endothelial lipase, hepatic lipase, and lipoprotein lipase simultaneous independent risk factors for CAD and in-stent restenosis?
Case-Control (n=189)
Are serum endothelial lipase, hepatic lipase, and lipoprotein lipase simultaneous independent risk factors for CAD and in-stent restenosis?
Serum endothelial lipase, hepatic lipase, and lipoprotein lipase are simultaneous independent risk factors for CAD, and their combined assessment provides superior predictive power compared to HDL-c.
AIM: Endothelial lipase (EL), hepatic lipase (HL), and lipoprotein lipase (LPL) are all triglyceride lipases and are associated with coronary artery disease (CAD). However, whether they can be simultaneous independent risk factors for CAD is unknown. In the present study, we investigated whether the three lipases can be independent risk factors simultaneously for CAD and whether combining these lipases could provide greater predictive power than high-density lipoprotein cholesterol (HDL-c) for the development of CAD. METHODS: Eighty-six patients with CAD and 65 healthy controls were enrolled in the study. Additionally, 38 patients who underwent one-year follow-up angiography after percutaneous coronary intervention with stent implantation were collected to investigate in-stent restenosis. Serum EL, HL, and LPL concentrations were measured and compared with other coronary risk factors. RESULTS: Serum EL and HL concentrations were both significantly increased in patients with CAD or in-stent restenosis, whereas serum LPL concentration was reduced significantly in patients with CAD. Multivariate logistic regression analysis indicated that the three lipases were simultaneous independent risk factors for CAD. However, only serum EL concentration was considered an independent risk factor for in-stent restenosis. Importantly, the receiver operating characteristic curve showed that the combined measurement of the three lipases displayed better predictive power than HDL-c or any one of the three lipases for CAD. CONCLUSIONS: Serum EL concentration was an independent risk factor for both CAD and in-stent restenosis. Moreover, the combined assessment of serum EL, HL, and LPL concentrations as multiple risk factors provided potent predictive power for CAD.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2019) conducted a case-control in Coronary Artery Disease and In-Stent Restenosis (n=189). Serum triglyceride lipases (EL, HL, LPL) vs. Healthy controls and HDL-c was evaluated on Presence of coronary artery disease and in-stent restenosis. Combined assessment of serum endothelial, hepatic, and lipoprotein lipases provided better predictive power for coronary artery disease than HDL-c, and EL independently predicted in-stent restenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: